Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paolo Fundaro Insider Profile
4 Followers
Paolo Fundaro, Director, Ten Percent Owner at Intercept Pharma, holds 4.02M shares in Intercept Pharma (Ticker: ICPT). Most recently, Paolo Fundaro Sold $1,500,000 shares of Intercept Pharma on Aug 17, 2020 for an estimated value of 71.25M.
Paolo Fundaro Intercept Pharma (ICPT)Director, Ten Percent Owner
Intercept Pharma (ICPT)
Director, Ten Percent Owner
Ranked #17,680 out of 78,624 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+20.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director, Ten Percent Owner
Roles that Paolo Fundaro holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paolo Fundaro
Paolo Fundaro's Trading History
List of latest transactions for each holding click on a transaction to see Paolo Fundaro's performance on stock
You May Also Like
Paolo Fundaro insider profile FAQ
What is the percentage of profitable transactions made by Paolo Fundaro?
The percentage of profitable transactions made by Paolo Fundaro is 75%.
What is the average return per transaction made by Paolo Fundaro?
The average return per transaction made by Paolo Fundaro is 20.10%.
What stocks does Paolo Fundaro hold?
Paolo Fundaro holds: ICPT stocks.
What was Paolo Fundaro’s latest transaction?
Paolo Fundaro latest transaction was an Informative Sell of $71.25M.
What was Paolo Fundaro's most profitable transaction?
Paolo Fundaro’s most profitable transaction was an Informative Sell of ICPT stock on May 15, 2020. The return on the trade was 55.90%.
What is Paolo Fundaro's role in Intercept Pharma?
Paolo Fundaro's role in Intercept Pharma is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.